exome sequencing Archives

TAG:

exome sequencing

In Florida, More Tests Added to UHC’s Decision-Support Program

By Joseph Burns | From the Volume XXV No. 1 – January 2, 2018 Issue

IN THE FIRST BROAD EXPANSION OF ITS pilot decision-support program for clinical lab testing in Florida, UnitedHealthcare (UHC) will add genetic and molecular tests, drug tests, and pathology procedures, among other assays starting in two months. On March 1, UHC will expand its labor…

Clinical Labs Bidding Up Lab Director Salaries

By Joseph Burns | From the Volume XXIV No. 3 – February 21, 2017 Issue

CEO SUMMARY: There’s great news for pathologists and PhDs with expertise in molecular and genetic testing. Salaries are on the rise as more clinical labs build up their molecular and genetic testing programs and need talent to implement and supervise this activity. One experienced medic…

$26 Million Recoupment from Medicare Audit Hammers Pharmacogenomic Lab

By Joseph Burns | From the Volume XXIV No. 1 – January 9, 2017 Issue

CEO SUMMARY: After Pharmacogenetics Diagnostic Laboratory LLC was audited by a Medicare Zone Program Integrity Contractor (ZPIC), it faced a $26 million repayment demand. The lab company appealed and asked for a redetermination, then filed for Chapter 11 bankruptcy protection. These devel…

Pharmacogenomic Testing Draws $26 Million Recoupment from Medicare Audit

By Mary Van Doren | From the Volume XXIV No. 1 – January 9, 2017 Issue

This is an excerpt from a 1,340-word article in the January 9 issue of THE DARK REPORT. The complete article is available for a limited time to all readers, and available at all times to paid members of the Dark Intelligence Group. CEO SUMMARY: Phar…

Cigna Expands Program For Genetic Counseling When Genetic Tests Are Needed

By Joseph Burns | From the Volume XXIII No. 11 – August 15, 2016 Issue

CEO SUMMARY: For three years, Cigna has required genetic counseling for members seeking genetic testing for hereditary breast, ovarian, and colorectal cancer, and for a particular heart condition. Such counseling increased member satisfaction, causing Cigna to expand the program. It now r…

How to Cover Genetic Tests Confounds Health Insurers

By Joseph Burns | From the Volume XXIII No. 5 – April 11, 2016 Issue

CEO SUMMARY: Managed care experts say health insurers are being overwhelmed by the number of new genetic tests and that many labs find it tough to get paid for these tests. UnitedHealthcare just announced it will require pre-authorization of molecular and genetic tests during 2016. Me…

New Company Tracks Details and Prices For 60,000 Molecular and Genetic Tests

By Joseph Burns | From the Volume XXIII, No. 1 – January 19, 2016 Issue

CEO SUMMARY: Advances in the speed, accuracy, and cost of next-generation gene sequencing making it possible for clinical labs to create thousands of new tests. How many new tests? NextGxDx, an information technology company, says the nation’s clinical laboratories are introducing new m…

2015’s Top 10 Lab Stories Show Significant Changes

By Robert Michel | From the Volume XXII, Number 18 – December 28, 2015 Issue

CEO SUMMARY: During 2015, two stories captured the full attention of most pathologists and clinical lab managers. One was how CMS intends to gather lab price market data as mandated by PAMA. The other was the continued efforts by the FDA to move ahead on proposed guidance for regulation o…

Newer, Smaller Analyzers Will Bring Big Data to Labs

By Joseph Burns | From the Volume XXII No. 10 – July 13, 2015 Issue

CEO SUMMARY: Clinical laboratories of all sizes are poised to become the source of much of a hospital or health system’s “big data.” At many academic center labs, greater use of genetic and molecular testing requires that more space and more staff be devoted to data management. A…

Claritas Is Example of New Lab Business Model

By Joseph Burns | From the Volume XXI No. 1 – January 13, 2014 Issue

CEO SUMMARY: One by one, new business models for clinical laboratory testing are popping up. Each is a response to healthcare’s rapid evolution, the ongoing decline in lab test reimbursement, and the growing role for molecular diagnostics and genetic testing. In Cambridge, Massachusetts…

Volume XXXI, No. 16 – November 25, 2024

Two different federal lawsuits that challenge the authority of the federal Food and Drug Administration (FDA) to regulate laboratory developed tests (LDTs) will be combined. Plaintiffs and the government in both cases agreed to move forward on this basis.

See the full table of contents

How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Need A Group Membership? Company Discounts are Available!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

Topics

Visit The Dark Library

TAG:

exome sequencing

CURRENT ISSUE

How Much Laboratory Business Intelligence Have You Missed?

Sign up for TDR Insider

Topics